## MEDP: Medpace Holdings, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 0.9% below STRENGTH zone (4.0-10.0%); PEG 3.60 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($541.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Osaic Holdings Inc. Raises Stake in Medpace Holdings, Inc. $MEDP**
- Source: MarketBeat | 20251229T100917 | Neutral | Relevance: 100%
- Osaic Holdings Inc. increased its stake in Medpace Holdings, Inc. by 55.4% during Q2, now holding 6,334 shares valued at $1.99 million, contributing to institutional ownership of nearly 78%. Despite significant insider selling totaling over $233 million in the last 90 days, analysts maintain a consensus "Hold" rating with a target price of $490.82, contrasting with the current trading price around $567.56. Medpace recently reported strong Q3 earnings, exceeding analyst estimates for both EPS and revenue.

**2. Medpace Holdings, Inc. $MEDP Shares Sold by PineStone Asset Management Inc.**
- Source: MarketBeat | 20251228T130941 | Neutral | Relevance: 100%
- PineStone Asset Management Inc. reduced its stake in Medpace Holdings, Inc. by 19.6% in the third quarter, while institutional investors collectively own 77.98% of the stock. Despite significant insider selling over the past three months, Medpace's fundamentals remain strong, with the company beating Q3 earnings expectations and providing optimistic FY2025 EPS guidance. Wall Street analysts currently give the stock a "Hold" rating with an average target price of $490.82.

**3. Cwm LLC Has $14.65 Million Holdings in Medpace Holdings, Inc. $MEDP**
- Source: MarketBeat | 20251228T090914 | Somewhat-Bullish | Relevance: 100%
- Cwm LLC significantly increased its stake in Medpace Holdings, Inc. ($MEDP) by 311.4% in Q3, now owning 28,496 shares valued at $14.65 million. Despite substantial insider selling that totaled $233.39 million, institutional ownership remains high, and Medpace recently exceeded EPS and revenue estimates, providing optimistic FY2025 guidance. Wall Street analysts currently hold a mixed "Hold" rating with an average target price of $490.82.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Barclays | $525 | $485 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Barclays | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.82M) |
| Sells | 26 ($217.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Blackrock Inc.: 8.4% (-4.4%)
- Vanguard Group Inc: 8.1% (-4.5%)
- AQR Capital Manageme: 3.6% (+65.1%)
- Wasatch Advisors LP: 3.3% (-2.1%)
- State Street Corpora: 2.4% (-4.8%)

### Key Risks

1. Heavy insider selling: $217M sold (26 transactions in 90 days).
2. Valuation stretched: PEG 3.6x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 3.60 signals overvaluation risk, limited margin of safety. Forward P/E 34.4x stretched relative to 9% growth. Quality metrics strong (ROE 74%, ROA 16%, margin 18%). Analyst sentiment positive (1 raises, avg +8%). Insider selling cluster ($217.3M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.0B |
| Beta | 1.43 |
| 52W Range | $250.05 - $626.25 |
| Short Interest | 6.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.60 |
| Forward P/E | 34.4 |
| Current P/E | 37.6 |
| YoY Growth | 9.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -0.8% to 0.9% (+1.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.0pp (needs >4.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. MACD histogram positive (1.21), confirming momentum. RSI neutral at 50. OFD pattern: -DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.95% (CS: 66) | Neutral |
| RSI_14 | 49.9 | Neutral |
| MACD Histogram | 1.21 | Bullish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 0.983x | Below |
| vs SMA200 | 1.325x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $568.85
- **Stop Loss:** $541.31 (4.8% risk)
- **Target:** $596.39 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 47
- **Position Value:** $26,735.95
- **Portfolio %:** 26.74%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-09 (Est: $4.21)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.57 | $3.86 | +8.1% |
| 2025Q2 | $3.00 | $3.10 | +3.5% |
| 2025Q1 | $3.07 | $3.67 | +19.6% |
| 2024Q4 | $3.12 | $3.68 | +18.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*